Chlamydiaceae Infections: Clinical Trials

170 trials for Chlamydiaceae Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

110 completed, 15 recruiting, 13 terminated, 12 not yet recruiting. 67 Not applicable, 31 Phase 4, 21 Phase 3, 12 Phase 2, 4 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable67Completed 42, Not yet recruiting 7, Recruiting 7, Terminated 6, Unknown 4, Withdrawn 1
Phase 431Completed 18, Withdrawn 5, Recruiting 3, Active not recruiting 2, Not yet recruiting 1, Terminated 1, Unknown 1
Phase 321Completed 13, Not yet recruiting 2, Terminated 2, Unknown 2, Recruiting 1, Withdrawn 1
Phase 212Completed 9, Not yet recruiting 1, Recruiting 1, Withdrawn 1
Phase 14Completed 3, Recruiting 1

Follow Chlamydiaceae Infections: new trials by email Literature Review of Chlamydiaceae Infections trials Research Report on Chlamydiaceae Infections

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans
Integrated care - Opioid Use Disorder, HIV
Not applicableNot yet recruitingVA Office of Research and Development602028-04-032026-04-24
Improving Clinic Delivery of HIV-related Anal Health Services
PEACHES 2.0 Implementation Strategies - HIV, Gonorrhea
Not applicableNot yet recruitingAlbert Einstein College of Medicine82028-02-012026-10-13
A Clinical Study to Assess the Efficacy of Weekly Doxycycline Prophylaxis to Reduce Bacterial Sexually Transmitted Infections (STI) in Young African Women
Doxycycline hyclate, Standard of Care for STI prevention - Sexually Transmitted Infection (STI), Gonorrhea
Phase 3Not yet recruitingNational Institute of Allergy and Infectious Diseases (NIAID)5802026-11-302026-10-20
Outcomes From Point-of-Care Sexually Transmitted Infection (STI) Testing in an Urban Sexual Health Clinic: A Randomized Trial
Point-of-care assay for chlamydia and gonorrhea, Laboratory-based chlamydia and gonorrhea NAAT, CRISPR-based assay - Neisseria Gonorrhoeae Infection, Chlamydia Trachomatis Infection
Not applicableNot yet recruitingMassachusetts General Hospital4002026-11-012026-10-06
Pilot HIV Self-Testing And Self-collected STI Testing Strategy for Sex Worker Empowerment Study
Venue-based, peer-enhanced strategy for integrated HIV self-testing (and self-collected STI testing - HIV, Syphilis
Not applicableNot yet recruitingUniversity of North Carolina, Chapel Hill2322026-10-012026-09-18
Strengthening, Guidance, Health, Empowerment
Self-sampling for six sexually transmitted infections - HIV Infection, Syphilis
Not applicableNot yet recruitingUniversity Hospital, Montpellier2002026-09-012026-08-26
Multicentre Study Evaluating the Efficacy of a 7-day Course of Doxycycline for the Treatment of Asymptomatic Anal Lymphogranuloma Venereum.
Doxycline - Lymphogranuloma Venereum, no Anorectal Symptoms
Phase 2Not yet recruitingUniversity Hospital, Bordeaux1202026-09-012026-08-17
National Rapid TLC: Testing and Linkage to Care
Xpert® HIV-1 Qual XC - HIV, Chlamydia
Not applicableNot yet recruitingUnity Health Toronto25002026-08-012026-07-28
Evaluation of the Impact of Oral Ivermectin on Musca Sorbens Flies, Putative Vector of Trachoma
Ivermectin - Survival of Flies Developing in Faecal Samples
Phase 4Not yet recruitingLondon School of Hygiene and Tropical Medicine122026-07-012026-06-18
Healthy Expectancy Through Routine Antenatal STI Screening
Chlamydia trachomatis and Neisseria gonorrhoeae screening - Antenatal Health, Antenatal Care
Not applicableRecruitingAdriane Wynn20002026-05-252026-07-02
Evaluation of Free STI Testing Pilot Projects in Lucerne and Zurich, Switzerland
HIV (Human Immunodeficiency Virus), Chlamydia
Not yet recruitingUniversity of Zurich18002026-04-072026-04-08
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Doxycycline hyclate delayed released 200 mg, Doxycycline hyclate delayed released 200 mg weekly, Per standard of care with quarterly STI testing/treatment and sexual health counseling - Gonorrhea, Chlamydia
Phase 4RecruitingWestat7602026-02-272026-10-16
Point of Care STI Testing
Gonorrhea/chlamydia Point-of-Care Testing - Point of Care STI Testing
Not applicableRecruitingIcahn School of Medicine at Mount Sinai64602026-02-242026-05-05
Adaptive RCT of Corticosteroids for Severe Chlamydia Psittaci Pneumonia in Adults
Saline (0.9%, sterile, for infusion), low dose Methylprednisolone, Moderate dose Methylprednisolone - Psittacosis
Phase 3Not yet recruitingQingyuan Zhan1002026-01-152026-01-20
RESTORE: Comparing Two Approaches to Repeat TT Surgery Performed by Integrated Eye Care Workers (IECWs)
B-RAP, BLTR - Trachoma, Eye Diseases
Not applicableRecruitingUniversity of North Carolina, Chapel Hill10002026-01-132026-04-13
Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Dengue, Chikungunya
RecruitingInstitut Pasteur du Cambodge100002025-12-182026-01-22
Using Urine to Study Antibodies & Functional Cell-Mediated Immunity in the Context of Chlamydia Trachomatis
Sampling - Chlamydia Trachomatis Genital Infection
RecruitingUniversiteit Antwerpen732025-12-102026-05-19
Periodic Presumptive Treatment vs. doxyPEP for STI Control in Kenyan MSM
WHO-recommended periodic presumptive treatment, Doxycycline post-exposure prophylaxis - Gonorrhea Male, Chlamydia (Male)
Phase 4RecruitingUniversity of Washington29002025-10-292025-11-19
Doxi-Rio: Study on the Use of Doxycycline to Prevent Sexually Transmitted Infections in Rio de Janeiro
Doxycycline - Sexually Transmitted Diseases, Syphilis
Not applicableRecruitingOswaldo Cruz Foundation2002025-10-282026-03-30
The Efficacy of Doxycycline Post Exposure Prophylaxis for Preventing STIs Among MSM in Bangkok, Thailand.
Doxycycline (200mg/day) - Syphilis Infection, Gonorrhea
Phase 4RecruitingBangrak STIs Center4002025-10-062026-02-09

Showing 20 of 170. Sign in to see all of them.

Narrower conditions

Chlamydia Infections (132)  ·  Gonorrhea (88)  ·  Sexually Transmitted Diseases (46)  ·  Trachoma (38)  ·  Syphilis (30)  ·  HIV Infections (18)  ·  Trichomonas Infections (15)  ·  Acquired Immunodeficiency Syndrome (13)  ·  Infections (7)  ·  Sexual Behavior (7)  ·  Trichiasis (6)  ·  Elephantiasis, Filarial (5)  ·  Vaginosis, Bacterial (5)  ·  Bacterial Infections (4)  ·  Disease (4)

Broader conditions

Bacterial Infections and Mycoses (170)  ·  Gram-Negative Bacterial Infections (170)  ·  Bacterial Infections (166)  ·  Infections (163)  ·  Genital Diseases (133)  ·  Urogenital Diseases (133)  ·  Sexually Transmitted Diseases, Bacterial (132)  ·  Communicable Diseases (131)  ·  Neisseriaceae Infections (89)  ·  Sexually Transmitted Diseases (87)  ·  Pathological Conditions, Signs and Symptoms (63)  ·  Pathologic Processes (60)  ·  Disease Attributes (54)  ·  Conjunctival Diseases (40)

Interventions

Azithromycin (27)  ·  Doxycycline (9)  ·  Ivermectin (4)  ·  Albendazole (3)  ·  Ceftriaxone (3)  ·  HIV Testing (2)  ·  Health (2)  ·  Mass Screening (2)  ·  Methods (2)  ·  Permethrin (2)  ·  Sodium Chloride (2)  ·  Standard of Care (2)  ·  Therapeutics (2)  ·  Water (2)  ·  Amoxicillin (1)

Sponsors

University of California, San Francisco (19)  ·  London School of Hygiene and Tropical Medicine (8)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (8)  ·  Johns Hopkins University (7)  ·  Centers for Disease Control and Prevention (6)  ·  Northwestern University (5)  ·  University of Pittsburgh (5)  ·  National Heart, Lung, and Blood Institute (NHLBI) (4)  ·  Emory University (3)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (3)  ·  University of California, Los Angeles (3)  ·  University of North Carolina, Chapel Hill (3)  ·  University of Washington (3)  ·  Arkansas Children's Hospital Research Institute (2)  ·  Columbia University (2)

Countries

United States (89)  ·  Ethiopia (11)  ·  United Kingdom (9)  ·  Tanzania (6)  ·  Australia (4)  ·  France (4)  ·  Botswana (3)  ·  Canada (3)  ·  Niger (3)  ·  Uganda (3)  ·  Belgium (2)  ·  China (2)  ·  Kenya (2)  ·  Malawi (2)  ·  Mexico (2)

Top investigators

Julius Schachter, PhD (5)  ·  Jim Carey, MPH (3)  ·  Tom Lietman, MD (3)  ·  Brian Mustanski, PhD (2)  ·  Catherine Oldenburg, ScD, MPH (2)  ·  Elodie Lebas, RN (2)  ·  Emily Gower, PhD (2)  ·  Emma Harding-Esch (2)  ·  Jeremy D Keenan, MD, MPH (2)  ·  Jesse L Clark, MD, MSc (2)  ·  Kieran S O'Brien, MPH (2)  ·  Matthew J Burton, PhD FRCOphth (2)  ·  Michael E Newcomb, Ph.D. (2)  ·  Paul Emerson, PhD (2)  ·  Ricky Hill, Ph.D. (2)

Results publications

PMID 31589610, PMID 21099596, PMID 21775837, PMID 22953007, PMID 37018493, PMID 37351709, PMID 11386956, PMID 11880389, PMID 12392124, PMID 12593898, PMID 12904390, PMID 12958275, PMID 15937765, PMID 16314767, PMID 16314768, PMID 16356945, PMID 16455891, PMID 16825373, PMID 16905024, PMID 17051493, PMID 17077230, PMID 17301105, PMID 17583820, PMID 18038280, PMID 18053199, PMID 18532873, PMID 19023429, PMID 19077198, PMID 19104366, PMID 19220138, PMID 19321868, PMID 19329003, PMID 19389002, PMID 19549331, PMID 19591608, PMID 19616720, PMID 19629306, PMID 19936044, PMID 20155838, PMID 20308834, PMID 20335410, PMID 20370481, PMID 20378636, PMID 20585275, PMID 21072224, PMID 21124216, PMID 21173720, PMID 21216000, PMID 21489882, PMID 21685340

NIH funding

5UG1EY030833 (2), R01AI048789 (2), U19AI084024 (2), 1IK2CX002822-01A1 (1), 1UG1EY028088 (1), 1UG1EY036891 (1), 5UM1AI106707 (1), 5UM1AI148684-03 (1), D43TW009340 (1), K23EY019881 (1), R01AI068107 (1), R01AI143439 (1), R01AI158826 (1), R01AI179838 (1), R01CA321103 (1)